학술논문

COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms
Document Type
Report
Author
Ostaszewski, MarekNiarakis, AnnaMazein, AlexanderKuperstein, InnaPhair, RobertOrta‐Resendiz, AurelioSingh, VidishaAghamiri, Sara SadatAcencio, Marcio LuisGlaab, EnricoRuepp, AndreasFobo, GiselaMontrone, CorinnaBrauner, BarbaraFrishman, GoarGómez, Luis Cristóbal MonrazSomers, JuliaHoch, MattiGupta, Shailendra KumarScheel, JuliaBorlinghaus, HannaCzauderna, TobiasSchreiber, FalkMontagud, ArnauDe Leon, Miguel PonceFunahashi, AkiraHiki, YusukeHiroi, NorikoYamada, Takahiro G.Dräger, AndreasRenz, AlinaNaveez, MuhammadBocskei, ZsoltMessina, FrancescoBörnigen, DanielaFergusson, LiamConti, MartaRameil, MariusNakonecnij, VanessaVanhoefer, JakobSchmiester, LeonardWang, MuyingAckerman, Emily E.Shoemaker, Jason E.Zucker, JeremyOxford, KristieTeuton, JeremyKocakaya, EbruSummak, Gökçe YağmurHanspers, KristinaKutmon, MartinaCoort, SusanEijssen, LarsEhrhart, FriederikeRex, Devasahayam Arokia BalayaSlenter, DeniseMartens, MarvinPham, NhungHaw, RobinJassal, BijayMatthews, LisaOrlic‐Milacic, MarijaSenff-Ribeiro, AndreaRothfels, KarenShamovsky, VeronicaStephan, RalfSevilla, CristofferVarusai, ThawfeekRavel, Jean‐MarieFraser, RupshaOrtseifen, VeraMarchesi, SilviaGawron, PiotrSmula, EwaHeirendt, LaurentSatagopam, VenkataWu, GuanmingRiutta, AndersGolebiewski, MartinOwen, StuartGoble, CaroleHu, XiaomingOverall, Rupert W.Maier, DieterBauch, AngelaGyori, Benjamin M.Bachman, John A.Vega, CarlosGrouès, ValentinVazquez, MiguelPorras, PabloLicata, LuanaIannuccelli, MartaSacco, FrancescaNesterova, AnastasiaYuryev, AntonDe Waard, AnitaTurei, DenesLuna, AugustinBabur, OzgunSoliman, SylvainValdeolivas, AlbertoEsteban‐Medina, MarinaPeña‐Chilet, MariaRian, KinzaHelikar, TomášPuniya, Bhanwar LalModos, DezsoTreveil, AgathaOlbei, MartonDe Meulder, BertrandBallereau, StephaneDugourd, AurélienNaldi, AurélienNoël, VincentCalzone, LaurenceSander, ChrisDemir, EmekKorcsmaros, TamasFreeman, Tom C.Augé, FranckBeckmann, Jacques S.Hasenauer, JanWolkenhauer, OlafWillighagen, Egon L.Pico, Alexander R.Evelo, Chris T.Gillespie, Marc E.Stein, Lincoln D.Hermjakob, HenningD' Eustachio, PeterSaez‐Rodriguez, JulioDopazo, JoaquinValencia, AlfonsoKitano, HiroakiBarillot, EmmanuelAuffray, CharlesBalling, RudiSchneider, Reinhard
Source
Molecular Systems Biology. October 2021, Vol. 17 Issue 10
Subject
Analysis
Health aspects
Data warehousing/data mining
Data mining -- Health aspects -- Analysis
Mining industry -- Health aspects -- Analysis
Medical research -- Analysis -- Health aspects
Community development -- Health aspects -- Analysis
COVID-19 -- Health aspects -- Analysis
Medicine, Experimental -- Analysis -- Health aspects
Mineral industry -- Health aspects -- Analysis
Language
English
Abstract
Introduction The coronavirus disease 2019 (COVID‐19) pandemic due to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has already resulted in the infection of over 250 million people worldwide, of whom [...]
: We need to effectively combine the knowledge from surging literature with complex datasets to propose mechanistic models of SARS‐CoV‐2 infection, improving data interpretation and predicting key targets of intervention. Here, we describe a large‐scale community effort to build an open access, interoperable and computable repository of COVID‐19 molecular mechanisms. The COVID‐19 Disease Map (C19DMap) is a graphical, interactive representation of disease‐relevant molecular mechanisms linking many knowledge sources. Notably, it is a computational resource for graph‐based analyses and disease modelling. To this end, we established a framework of tools, platforms and guidelines necessary for a multifaceted community of biocurators, domain experts, bioinformaticians and computational biologists. The diagrams of the C19DMap, curated from the literature, are integrated with relevant interaction and text mining databases. We demonstrate the application of network analysis and modelling approaches by concrete examples to highlight new testable hypotheses. This framework helps to find signatures of SARS‐CoV‐2 predisposition, treatment response or prioritisation of drug candidates. Such an approach may help deal with new waves of COVID‐19 or similar pandemics in the long‐term perspective.